Stocks and Investing
Stocks and Investing
Mon, May 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Francois Brisebois Maintained (ACHV) at Buy with Decreased Target to $11 on, May 13th, 2024
Francois Brisebois of Oppenheimer, Maintained "Achieve Life Sciences, Inc." (ACHV) at Buy with Decreased Target from $18 to $11 on, May 13th, 2024.
Francois has made no other calls on ACHV in the last 4 months.
There are 2 other peers that have a rating on ACHV. Out of the 2 peers that are also analyzing ACHV, 0 agree with Francois's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Francois
- Justin Walsh of "JonesTrading" Initiated at Strong Buy and Held Target at $20 on, Wednesday, April 17th, 2024
- Thomas Flaten of "Lake Street" Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, March 5th, 2024
Contributing Sources